Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 9 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

9 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Nov. 7, 2023 MED P 50 $68.89 $3,444 8,375 Direct +0.60% Acquired -83.0% (price as of 2026-10-05)
Aug. 8, 2023 MED P 38 $89.42 $3,398 8,326 Direct +0.46% Acquired -86.9% (price as of 2026-10-05)
May 9, 2023 MED P 13 $87.50 $1,138 5,170 Direct +0.25% Acquired -86.7% (price as of 2026-10-05)
Feb. 7, 2023 MED P 10 $114.97 $1,150 5,157 Direct +0.19% Acquired -89.8% (price as of 2026-10-05)
Nov. 8, 2022 MED P 10 $106.93 $1,069 5,148 Direct +0.19% Acquired -89.1% (price as of 2026-10-05)
Nov. 12, 2018 MED P 200 $156.23 $31,246 600 Direct +50.00% Acquired -92.5% (price as of 2026-10-05)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.